HMRC has issued a comprehensive manual covering the corporation tax implications of intangible asset ownership and transactions, alongside guidance on relief mechanisms for research and development activities. The manual addresses tax credits available for R&D spending, vaccines research relief provisions, and the tax treatment of contaminated land remediation costs. The guidance applies to UK businesses claiming R&D tax relief or managing intangible assets as part of their corporate tax position.
Source: HMRC (GOV.UK) – Read the original